LPA and androgen insensitivity syndrome: In this study, we discovered that the risk for recurrent vascular events is significantly higher in the patients whose on-statin Lp(a) levels ≥ 70 mg/dL and the change of Lp(a) was independently associated with the risk for recurrent vascular events in statin-treated patients with AIS, even in patients with LDL-C lower than 1.8 mmol/L.